Last updated on 12 Jul 2021
Owner Info
Inheris Pharmaceuticals, Inc.
150 North Riverside Plaza, Suite 1840
Chicago IL 60606, UNITED STATES OF AMERICA
Serial Number
2027129 filed on 17 Jun 2019
Correspondent
Kilpatrick Townsend & Stockton LLP
Mailstop: IP Docketing - 22,,
1100 Peachtree Street, Suite 2800,
UNITED STATES OF AMERICA
2027129
17 Jun 2019
NA
WORD
18 Dec 2018
US
Status Date | Action Taken |
---|---|
12th Jul 2021 | Status change to Voided |
29th Jan 2020 | International Registration in Australia Protected correspondence sent |
28th Jan 2020 | IP Right Registration Published |
28th Jan 2020 | Status change to Registered/Protected |
20th Jan 2020 | Owner name details updated |
16th Jan 2020 | Owner name details updated |
9th Jan 2020 | Amendment to Amend Owner Requested |
9th Jan 2020 | Full Assignment Requested |
19th Nov 2019 | Application Accepted correspondence sent |
18th Nov 2019 | IP Right Acceptance Published |